NCT03531307|Completed
Lactate Levels Correlates With Ki-67 in Brain Tumor Surgery
Lactate Levels at Beginning of Surgery Correlates With Ki-67 Labeling Index in Brain Tumors
Loading search results
Lactate Levels at Beginning of Surgery Correlates With Ki-67 Labeling Index in Brain Tumors
Sponsor study identifier
observational
100
1 country
1
Study Start
May 30, 2018
Actual (reported)Primary Completion
July 30, 2018
Actual (reported)Study Completion
August 2, 2018
Actual (reported)In neurosurgery, brain tumor patients show increased levels of lactate at the beginning of surgery. This has been related to malignancy. Ki-67 is a cell proliferation index used as a marker of tumor mitotic activity. This research aims to describe the correlation between lactate levels and the Ki-67 index in patients with brain tumor.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 24, 2018
Actual (reported)May 21, 2018
Actual (reported)May 30, 2018
Actual (reported)July 30, 2018
Actual (reported)August 2, 2018
Actual (reported)Evaluate the correlation between Lactate levels and Ki-67 Index
Levels of lactate in first blood analysis after anesthesia induction and proliferation index in biopsy results
Within 1 week after data acquisition
Neurosurgical patients between June 2017 and February 2018 for tumoral and non-tumoral craniectomy with lactate levels at the beginning of surgery and Ki-67 index in biopsies.
Correlation between lactate levels and Ki-67 index
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Craniectomy cases for tumoral and non-tumoral surgery with lactate levels and biopsy information.
Anesthesia department, Hospital Clínic de Barcelona
Barcelona, 08036, Spain
Ricard Valero, Dr.
Hospital Clinic of Barcelona
100 participants (actual enrollment reported by the registry).
First Submitted
April 24, 2018
First Posted
May 21, 2018
Study Start
May 30, 2018
Actual (reported)[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
Contact the study team to confirm eligibility.
Primary Completion
July 30, 2018
Actual (reported)Study Completion
August 2, 2018
Actual (reported)Last Updated
February 15, 2019
Record last verified: 2019-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: